
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort”, PLoS One, vol. 11, p. e0151587, 2016.
, “An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population”, BMC Fam Pract, vol. 14, p. 28, 2013.
, “Epidemiology and treatment of neuropathic pain: the UK primary care perspective”, Pain, vol. 122, pp. 156-62, 2006.
, “Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database”, Pharmacoepidemiol Drug Saf, vol. 15, pp. 555-64, 2006.
, “Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database”, Pharmacoepidemiol Drug Saf, vol. 13, pp. 749-59, 2004.
, “Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice”, Neurology, vol. 62, pp. 563-8, 2004.
, “Micturin (Terodiline Hydrochloride), Torsades de Pointe and other Arrhythmias — A Study using the VAMP Database”, Pharmacoepidemiology and Drug Safety, vol. 2, pp. 127-132, 1993.
, “A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom”, Pharmacotherapy, vol. 10, pp. 395-7, 1990.
,